Regeneron stops trial after drug fails to help coronavirus patients

Regeneron Pharmaceuticals and Sanofi have shut down the late-stage clinical trial that was testing whether their existing arthritis drug, Kevzara, could improve the condition of COVID-19 patients who were on ventilators.The bottom line: Kevzara fared no bette…
Read More

Leave a Reply

%d bloggers like this: